GENEVA, June 19 -- LEAL THERAPEUTICS, INC. filed a patent application (US2025/055244) for “USE OF SMALL MOLECULE GLUTAMINASE INHIBITORS FOR TREATING AGE-RELATED DISORDERS”. With publication no. WO/2026/107134, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....